v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Operating activities          
Net Loss $ (9,283) $ (4,257) $ (22,565) $ (28,532)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Credit loss expense     1,833 3,761  
Depreciation and amortization     12,566 12,779  
Amortization of financing costs charged to interest expense     804 850  
Amortization of right-of-use assets     1,274 1,072  
Gain on disposal or divestiture 200 0 (5,150) 0 $ 100
Gain on debt extinguishment 0 (13,017) 0 (13,017)  
Stock-based compensation expense     16,195 23,629  
Change in contingent consideration     (102) (9)  
Other non-cash (income) expense, net     (8,076) 663  
Change in operating assets and liabilities:          
Accounts receivable     10,165 14,783  
Prepaid expenses and other assets     (1,625) (393)  
Accounts payable     (1,837) 810  
Other accrued expenses     920 (7,253)  
Partner Share liability     (5,913) (15,114)  
Consumer Incentive liability     (4,174) (7,234)  
Net cash used in operating activities     (5,481) (13,188)  
Investing activities          
Acquisition of property and equipment     (441) (932)  
Capitalized software development costs     (8,320) (8,673)  
Business divestiture and acquisitions, net of cash acquired     200 202  
Net cash used in investing activities     (8,561) (9,403)  
Financing activities          
Settlement of contingent consideration     (5,000) (14,166)  
Principal payments of the 2018 Line of Credit     0 (30,000)  
Principal payments of 2020 Convertible Senior Notes     0 (169,291)  
Proceeds from issuance of 2024 Convertible Senior Notes     0 172,500  
Proceeds from termination of capped calls related to convertible notes     0 115  
Proceeds from issuance of common stock     0 48,634  
Equity issuance costs     0 (190)  
Debt issuance costs     (93) (5,568)  
Net cash (used in) provided by financing activities     (5,093) 2,034  
Effect of exchange rates on cash and cash equivalents     286 (25)  
Net decrease in cash and cash equivalents     (18,849) (20,582)  
Cash and cash equivalents — Beginning of period     65,594 91,830 91,830
Cash and cash equivalents — End of period $ 46,745 $ 71,248 46,745 71,248 $ 65,594
Supplemental disclosure of cash flow information:          
Cash paid for interest     3,941 2,202  
Amounts accrued for property and equipment     0 378  
Amounts accrued for capitalized software development costs     134 150  
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)     0 27,451  
Amounts accrued for debt issuance costs     $ 0 $ 354